T1	Participants 47 94	patients treated for a hematological malignancy
T2	Participants 246 281	patients with prolonged neutropenia
T3	Participants 576 670	Evaluation of the clinician's compliance with these rules in 1951 febrile neutropenic episodes
T4	Participants 738 753	761 (39%) cases
